November 21, 2023 01:13 PM ESTUpdated November 22, 06:07 AM

Europe revokes one of Moderna's Covid vaccine patents following opposition from BioNTech, Pfizer

Katherine Lewin

News Reporter

In the European battlefield of mRNA litigation, Moderna took a blow after the European Patent Office declared one of its patents covering its Covid-19 vaccine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Europe revokes one of Moderna's Covid vaccine patents following opposition from BioNTech, Pfizer

Katherine Lewin

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

UK’s price watchdog says Lilly’s Alzheimer’s drug is too costly for broad uptake

Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won't need confirmatory study

Amgen preps to launch Eylea biosimilar years early after Regeneron loses appeal

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Eu­rope re­vokes one of Mod­er­na's Covid vac­cine patents fol­low­ing op­po­si­tion from BioN­Tech, Pfiz­er

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Europe revokes one of Moderna's Covid vaccine patents following opposition from BioNTech, Pfizer